Shuangsong Ren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shuangsong Ren has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ying Che
Department of Ultrasound, The First Affiliated Hospital of Dalian Medical University
4 shared publications Mengying Tong
Department of Ultrasound, The First Affiliated Hospital of Dalian Medical University
3 shared publications- Ye Qi
State Key Laboratory of Fine Chemicals School of Chemical Engineering Dalian University of Technology 2 Linggong Road Dalian Liaoning 116024 P. R. China
3 shared publications Fang Yang
Department of Ultrasound, Affiliated People’s Hospital of Nankai University
2 shared publications- Guiling Ning
Dalian Univ Technol, Sch Chem Engn, State Key Lab Fine Chem, 2 Linggong Rd, Dalian 116024, Liaoning, Peoples R China
2 shared publications Jun Li
2 shared publications
Latest Publications
- Open Access
- 13 September 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (23)
Copper‐Single‐Atom Coordinated Nanotherapeutics for Enhanced Sonothermal‐Parallel Catalytic Synergistic Cancer Therapy (Adv. Healthcare Mater. 23/2023)
- 13 September 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (23)
Open AccessCopper‐Single‐Atom Coordinated Nanotherapeutics for Enhanced Sonothermal‐Parallel Catalytic Synergistic Cancer Therapy (Adv. Healthcare Mater. 23/2023)
- 23 May 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (23) , e2300291
Copper‐Single‐Atom Coordinated Nanotherapeutics for Enhanced Sonothermal‐Parallel Catalytic Synergistic Cancer Therapy
Phototherapy and sonotherapy are recognized by scientific medicine as effective strategies for treating certain cancers. However, these strategies have limitations such as an inability to penetrate deeper tissues and overcome the antioxidant tumor microenvironment. In this study, a novel “BH” interfacial‐confined coordination strategy to synthesize hyaluronic acid‐functionalized single copper atoms dispersed over boron imidazolate framework‐derived nanocubes (HA‐NC_Cu) to achieve sonothermal–catalytic synergistic therapy is reported. Notably, HA‐NC_Cu demonstrates exceptional sonothermal conversion performance under low‐intensity ultrasound irradiation, attained through intermolecular lattice vibrations. In addition, it shows promise as an efficient biocatalyst, able to generate high‐toxicity hydroxyl radicals in response to tumor‐endogenous hydrogen peroxide and glutathione. Density functional theory calculations reveal that the superior parallel catalytic performance of HA‐NC_Cu originates from the CuN4C/B active sites. Both in vitro and in vivo evaluations consistently demonstrate that the sonothermal–catalytic synergistic strategy significantly improves tumor inhibition rate (86.9%) and long‐term survival rate (100%). In combination with low‐intensity ultrasound irradiation, HA‐NC_Cu triggers a dual death pathway of apoptosis and ferroptosis in MDA‐MB‐231 breast cancer cells, comprehensively limiting primary triple‐negative breast cancer. This study highlights the applications of single‐atom‐coordinated nanotherapeutics in sonothermal–catalytic synergistic therapy, which may create new opportunities in biomedical research.
- 23 May 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 12 (23) , e2300291
Copper‐Single‐Atom Coordinated Nanotherapeutics for Enhanced Sonothermal‐Parallel Catalytic Synergistic Cancer Therapy
Phototherapy and sonotherapy are recognized by scientific medicine as effective strategies for treating certain cancers. However, these strategies have limitations such as an inability to penetrate deeper tissues and overcome the antioxidant tumor microenvironment. In this study, a novel “BH” interfacial‐confined coordination strategy to synthesize hyaluronic acid‐functionalized single copper atoms dispersed over boron imidazolate framework‐derived nanocubes (HA‐NC_Cu) to achieve sonothermal–catalytic synergistic therapy is reported. Notably, HA‐NC_Cu demonstrates exceptional sonothermal conversion performance under low‐intensity ultrasound irradiation, attained through intermolecular lattice vibrations. In addition, it shows promise as an efficient biocatalyst, able to generate high‐toxicity hydroxyl radicals in response to tumor‐endogenous hydrogen peroxide and glutathione. Density functional theory calculations reveal that the superior parallel catalytic performance of HA‐NC_Cu originates from the CuN4C/B active sites. Both in vitro and in vivo evaluations consistently demonstrate that the sonothermal–catalytic synergistic strategy significantly improves tumor inhibition rate (86.9%) and long‐term survival rate (100%). In combination with low‐intensity ultrasound irradiation, HA‐NC_Cu triggers a dual death pathway of apoptosis and ferroptosis in MDA‐MB‐231 breast cancer cells, comprehensively limiting primary triple‐negative breast cancer. This study highlights the applications of single‐atom‐coordinated nanotherapeutics in sonothermal–catalytic synergistic therapy, which may create new opportunities in biomedical research.
- Open Access
- 7 August 2022
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 39 (1) , 1036-1043
Different effects of intravenous and local anesthesia in patients undergoing ultrasound-guided radiofrequency ablation of thyroid nodules: a prospective cohort study
To compare the efficacy and safety of intravenous anesthesia (IV) with local anesthesia (LA) in patients undergoing ultrasound (US)-guided radiofrequency ablation (RFA) of thyroid nodules.50 patien...
- 7 August 2022
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 39 (1) , 1036-1043
Open AccessDifferent effects of intravenous and local anesthesia in patients undergoing ultrasound-guided radiofrequency ablation of thyroid nodules: a prospective cohort study
To compare the efficacy and safety of intravenous anesthesia (IV) with local anesthesia (LA) in patients undergoing ultrasound (US)-guided radiofrequency ablation (RFA) of thyroid nodules.50 patien...
- 4 May 2022
- Published by Wiley in Advanced Therapeutics
- Vol. 5 (6)
Boron Imidazolate Framework‐Derived Porous Carbon Nanospheres for Dual‐Mode Bioimaging‐Guided Photothermal/Sonodynamic Synergistic Cancer Therapy
Development of efficient nanotherapeutic agents to enhance anticancer therapeutic effects is challenging. In this study, photo/sono‐dual‐responsive boron imidazolate framework‐derived single‐component porous carbon nanospheres (PCNSs) are successfully developed for dual‐mode bioimaging‐guided photothermal/sonodynamic (PTT/SDT) synergistic therapy for triple‐negative breast cancer. The PCNS not only exhibits satisfactory and excellent photothermal conversion ability under near‐infrared laser irradiation but also demonstrates a promising capability as an efficient sonosensitizer to generate cytotoxic reactive oxygen species through inertial cavitation in response to low‐intensity ultrasound stimulation. The outstanding photothermal effect enhances the blood flow in tumor tissues and thus improves the oxygen supply, helping to achieve a remarkable synergistic therapeutic effect in the PTT/SDT synergistic therapy without any tumor recurrence or systemic toxicity. Interestingly, the PCNS enables the precise visualization of solid tumors using contrast‐enhanced ultrasound and photothermal dual‐modal bioimaging techniques. Overall, this study provides valuable insights in developing all‐in‐one theranostic nanoplatforms for the clinical treatment of triple‐negative breast cancer.
- 4 May 2022
- Published by Wiley in Advanced Therapeutics
- Vol. 5 (6)
Boron Imidazolate Framework‐Derived Porous Carbon Nanospheres for Dual‐Mode Bioimaging‐Guided Photothermal/Sonodynamic Synergistic Cancer Therapy
Development of efficient nanotherapeutic agents to enhance anticancer therapeutic effects is challenging. In this study, photo/sono‐dual‐responsive boron imidazolate framework‐derived single‐component porous carbon nanospheres (PCNSs) are successfully developed for dual‐mode bioimaging‐guided photothermal/sonodynamic (PTT/SDT) synergistic therapy for triple‐negative breast cancer. The PCNS not only exhibits satisfactory and excellent photothermal conversion ability under near‐infrared laser irradiation but also demonstrates a promising capability as an efficient sonosensitizer to generate cytotoxic reactive oxygen species through inertial cavitation in response to low‐intensity ultrasound stimulation. The outstanding photothermal effect enhances the blood flow in tumor tissues and thus improves the oxygen supply, helping to achieve a remarkable synergistic therapeutic effect in the PTT/SDT synergistic therapy without any tumor recurrence or systemic toxicity. Interestingly, the PCNS enables the precise visualization of solid tumors using contrast‐enhanced ultrasound and photothermal dual‐modal bioimaging techniques. Overall, this study provides valuable insights in developing all‐in‐one theranostic nanoplatforms for the clinical treatment of triple‐negative breast cancer.
- Open Access
- 1 January 2021
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 38 (1) , 1225-1232
Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study
To confirm the long-term efficacy and safety of radiofrequency ablation (RFA) for low-risk papillary thyroid microcarcinoma (PTMC).We retrospectively reviewed data of 102 primary papillary thyroid ...
- 1 January 2021
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 38 (1) , 1225-1232
Open AccessLong-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study
To confirm the long-term efficacy and safety of radiofrequency ablation (RFA) for low-risk papillary thyroid microcarcinoma (PTMC).We retrospectively reviewed data of 102 primary papillary thyroid ...